133 related articles for article (PubMed ID: 31054321)
1. Comparison of toluidine blue 1% staining patterns in cytopathologically confirmed ocular surface squamous neoplasias and in non-neoplastic lesions.
Aliakbar Navahi R; Hosseini SB; Kanavi MR; Rakhshani N; Aghaei H; Kheiri B
Ocul Surf; 2019 Jul; 17(3):578-583. PubMed ID: 31054321
[TBL] [Abstract][Full Text] [Related]
2. Toluidine Blue 0.05% Vital Staining for the Diagnosis of Ocular Surface Squamous Neoplasia in Kenya.
Gichuhi S; Macharia E; Kabiru J; Zindamoyen AM; Rono H; Ollando E; Wanyonyi L; Wachira J; Munene R; Onyuma T; Jaoko WG; Sagoo MS; Weiss HA; Burton MJ
JAMA Ophthalmol; 2015 Nov; 133(11):1314-21. PubMed ID: 26378623
[TBL] [Abstract][Full Text] [Related]
3. The use of 1% toluidine blue eye drops in the diagnosis of ocular surface squamous neoplasia.
Romero IL; Barros Jde N; Martins MC; Ballalai PL
Cornea; 2013 Jan; 32(1):36-9. PubMed ID: 22525782
[TBL] [Abstract][Full Text] [Related]
4. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
[TBL] [Abstract][Full Text] [Related]
5. Ocular Surface Epithelial Atypia Mimicking Squamous Neoplasia in Association With Ulcerative Colitis.
Ong SS; Walter SD; Chen X; Vora GK; Daluvoy M; Proia AD; Mruthyunjaya P
Cornea; 2017 Apr; 36(4):502-505. PubMed ID: 28129293
[TBL] [Abstract][Full Text] [Related]
6. The cytomorphology of ocular surface squamous neoplasia by using impression cytology.
Nolan GR; Hirst LW; Bancroft BJ
Cancer; 2001 Feb; 93(1):60-7. PubMed ID: 11241267
[TBL] [Abstract][Full Text] [Related]
7. Toluidine blue 1% eye drop versus optical coherence tomography for margin delimitation of ocular surface squamous neoplasia.
Ferraz FB; Castelo Branco AMP; da Cruz LGI; Fernandes BF; Morales MC; Neto RB; Fernandes AG
Eur J Ophthalmol; 2024 May; 34(3):859-863. PubMed ID: 37743595
[TBL] [Abstract][Full Text] [Related]
8. Histopathological spectrum of ocular surface squamous neoplasia: A retrospective study of 776 lesions.
Mishra DK; Taneja S; Singh V; Veena U; Kaliki S
Indian J Pathol Microbiol; 2022; 65(1):3-7. PubMed ID: 35074957
[TBL] [Abstract][Full Text] [Related]
9. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
Kaliki S; Bejjanki KM; Desai A; Mohamed A
Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
[TBL] [Abstract][Full Text] [Related]
10. Use of High-Resolution Optical Coherence Tomography in the Surgical Management of Ocular Surface Squamous Neoplasia: A Pilot Study.
Karp CL; Mercado C; Venkateswaran N; Ruggeri M; Galor A; Garcia A; Sivaraman KR; Fernandez MP; Bermudez A; Dubovy SR
Am J Ophthalmol; 2019 Oct; 206():17-31. PubMed ID: 31163136
[TBL] [Abstract][Full Text] [Related]
11. Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment.
Gandolfo S; Pentenero M; Broccoletti R; Pagano M; Carrozzo M; Scully C
Oral Oncol; 2006 Jan; 42(1):89-95. PubMed ID: 16256415
[TBL] [Abstract][Full Text] [Related]
12. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
Chaugule SS; Park J; Finger PT
Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
[TBL] [Abstract][Full Text] [Related]
13. Identification of ocular surface squamous neoplasia by in vivo staining with methylene blue.
Steffen J; Rice J; Lecuona K; Carrara H
Br J Ophthalmol; 2014 Jan; 98(1):13-5. PubMed ID: 24158840
[TBL] [Abstract][Full Text] [Related]
14. Predictive index to differentiate invasive squamous cell carcinoma from preinvasive ocular surface lesions by impression cytology.
Barros JN; Lowen MS; Ballalai PL; Mascaro VL; Gomes JA; Martins MC
Br J Ophthalmol; 2009 Feb; 93(2):209-14. PubMed ID: 19019933
[TBL] [Abstract][Full Text] [Related]
15. Use of impression cytology for the detection of unsuspected ocular surface squamous neoplasia cells in pterygia.
Barros JD; Lowen MS; Moraes-Filho MN; Martins MC
Arq Bras Oftalmol; 2014 Oct; 77(5):305-309. PubMed ID: 25494377
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of autofluorescence and toluidine blue in the differentiation of oral dysplastic and neoplastic lesions from non dysplastic and neoplastic lesions: a cross-sectional study.
Petruzzi M; Lucchese A; Nardi GM; Lauritano D; Favia G; Serpico R; Grassi FR
J Biomed Opt; 2014; 19(7):76003. PubMed ID: 24996662
[TBL] [Abstract][Full Text] [Related]
17. Impression cytology for detection of clinically suspected ocular surface disorders: A cross-sectional study.
Moshtaghion SM; Abolhosseini M; Rezaei Kanavi M; Hosseini SB; Rezaei Kanavi M
Eur J Ophthalmol; 2021 May; 31(3):943-950. PubMed ID: 32506955
[TBL] [Abstract][Full Text] [Related]
18. Impression cytology of ocular surface in xeroderma pigmentosum.
Marcos AAA; Freitas D; Barros JN; Fernandes AG; Lowen M; Rigueiro M; Morales MC; Belfort Neto R; Singh AD
Arq Bras Oftalmol; 2024; 87(4):e2023. PubMed ID: 38656021
[TBL] [Abstract][Full Text] [Related]
19. Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity.
Murube J; Rivas L
Eur J Ophthalmol; 2003 Mar; 13(2):115-27. PubMed ID: 12696629
[TBL] [Abstract][Full Text] [Related]
20. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia.
Kieval JZ; Karp CL; Abou Shousha M; Galor A; Hoffman RA; Dubovy SR; Wang J
Ophthalmology; 2012 Mar; 119(3):481-6. PubMed ID: 22154538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
